Synapse - Works

Results (115372)

Prostate cancer incidence and mortality after stop age in the Goteborg branch of ERSPC

Meeting Abstract

Hugosson, J.; Frånlund, M.; Godtman, R. A.; Aus, G.; Bergdahl, A. G.; Khatami, A.; Lodding, P.; Pihl, C. G.; Stranne, J.; Månsson, M.; more...
European Urology (2023)

Fulltext@MSK | Save

Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemia: Topline efficacy and safety results from the pivotal Augment-101 phase 2 study

Meeting Abstract

Aldoss, I.; Issa, G. C.; Thirman, M.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; more...
Blood (2023)

Fulltext@MSK | Save

Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: Findings from nationally representative data

Meeting Abstract

Chan, J. S. K.; Satti, D. I.; Dee, E. C.; Sharma, G.; Virani, S. S.; Liu, T.; Tse, G.
European Heart Journal (2023)

Fulltext@MSK | Save

Association between immune checkpoint inhibitors and heart failure hospitalizations: A population-based self-controlled case series

Meeting Abstract

Chan, J. S. K.; Lee, T. T. L.; Chou, O. H. I.; Lee, Y. H. A.; Dee, E. C.; Ng, K.; Hui, J. M. H.; Leung, F. P.; Wong, W. T.; Liu, T.; more...
European Heart Journal (2023)

Fulltext@MSK | Save

EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV + P) vs chemotherapy (chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

Meeting Abstract

Powles, T. B.; Perez Valderrama, B.; Gupta, S.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Iyer, G.; Vulsteke, C.; Park, S. H.; Shin, S. J.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)

Meeting Abstract

Kim, D. W.; Goto, K.; Schram, A.; Hollebecque, A.; Rha, S. Y.; Nishino, K.; Duruisseaux, M.; Umemoto, K.; Park, J. O.; Leighl, N.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Kelly, W. K.; Danila, D. C.; Lin, C. C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Armstrong, A. J.; Pook, D. W.; Kim, M.; Dorff, T.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Comparisons of on new-onset prostate cancer in type 2 diabetes mellitus exposed to the SGLT2I and DPP4I: A population-based cohort study

Meeting Abstract

Chou, H. I.; Lu, L.; Chung, C. T.; Chan, J. S. K.; Chan, R. N. C.; Lee, Y. H. A.; Dee, E. C.; Ng, K.; Pui, H. H. H.; Lee, S.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2— , locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma

Meeting Abstract

Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y. J.; Enzinger, P. C.; Ilson, D. H.; van Cutsem, E.; Gallego Plazas, J.; Huang, J.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Meeting Abstract

Oh, D. Y.; Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Omori, T.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save